Corticotropin-releasing factor: effect on cerebral blood flow in physiologic and ischaemic conditions.
The expression of corticotrophin-releasing factor (CRF) receptors in cerebral arteries and arterioles suggests that CRF may modulate cerebral blood flow (CBF). In the present study, the effects of CRF, CRF-like peptides and the CRF broad spectrum antagonist DPhe-CRF on CBF have been investigated under normal physiologic conditions and in the margins of focal ischaemic insult. The experiments were carried out in anaesthetised and ventilated rats. Changes in CBF after subarachnoid microapplication of CRF and related peptides were assessed with a laser-Doppler flowmetry (LDF) probe. In the ischaemic animals, agents were injected approximately 60 minutes after permanent middle cerebral artery occlusion (MCAo). Microapplication of CRF and related peptides in normal rats into the subarachnoid space produced sustained concentration-dependent increases in CBF. This effect was attenuated by co-application with DPhe-CRF, which did not alter CBF itself. A second microapplication of CRF 30 min after the first failed to produce increases in CBF in normal animals. Microapplication of CRF in the subarachnoid space overlying the ischaemic cortex effected minor increases in CBF whereas D-Phe-CRF had no significant effect on CBF. Activation of the CRF peptidergic system increases CBF in the rat. Repeated activation of CRF receptors results in tachyphylaxis of the vasodilator response. CRF vasodilator response is still present after MCAo in the ischaemic penumbra, suggesting that the CRF peptidergic system may modulate CBF in ischaemic stroke.
De Michele
Manuela
M
Department of Neurological Science, I and II Faculty of Medicine, University La Sapienza, Viale Dell'Università, 30, 00185, Rome, Italy. manuela.demichele@uniroma1.it
Touzani
Omar
O
Foster
Alan C
AC
Fieschi
Cesare
C
Sette
Giuliano
G
McCulloch
James
J
D000818:Animals; D002545:Brain Ischemia / Q000503:physiopathology*; D002560:Cerebrovascular Circulation / Q000187:drug effects* / Q000502:physiology; D003346:Corticotropin-Releasing Hormone / Q000819:agonists / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D019332:Endothelin-1 / Q000494:pharmacology; D007150:Immunohistochemistry; D007267:Injections; D008297:Male; D020768:Middle Cerebral Artery / Q000502:physiology; D009479:Neuropeptides / Q000494:pharmacology; D051381:Rats; D011916:Rats, Inbred F344; D013346:Subarachnoid Space
D019332:Endothelin-1; D009479:Neuropeptides; D003346:Corticotropin-Releasing Hormone